Picture Berlin Partner Top News Amboss Secures EUR240m Funding 650x100px

Document › Details

MaaT Pharma. (10/15/21). "Press Release: MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris [ Not for US, CA, AU, JP or RK ]". Lyon.

	Region	France
	Organisation	MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT)
	Organisation 2	Euronext Paris S.A.
	Group	Euronext (Group)
	Product	MaaT013 (MaaT Pharma)
	Product 2	investment banking
	Person	Affagard, Hervé (MaaT Pharma 201507 CEO)

Original document
accessed by [iito] on 2021-10-15

Record changed: 2023-06-05

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT)

[1] MaaT Pharma. (6/21/23). "Press Release: MaaT Pharma Announces New Appointments to the Board and Executive Team". Lyon....
[2] MaaT Pharma. (12/1/20). "Press Release: MaaT Pharma Announces Series B Extension and Final Closing with Total of €25 Million ($29.5 Million)". Lyon....
[3] MaaT Pharma. (5/28/20). "Press Release: MaaT Pharma Appoints Savita Bernal as Chief Business Officer". Lyon....
[4] MaaT Pharma. (2/5/20). "Press Release: MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)